Authors


Amy J. Hoffman, MSN, PhD, RN

Latest:

Switching Places: From Nurse to Caregiver

Coordination of care and educating patients and their caregivers needs to be the standard of care.


Jose Lutzky, MD

Latest:

Jose Lutzky on Proactively Monitoring Patients Receiving Immunotherapy Treatments

Jose Lutzky, MD, discusses the importance of proactive patient monitoring with patients receiving immunotherapy treatments.


Pamela Haylock, PhD, RN, FAAN

Latest:

Pamela Haylock on the Role of CSTDs

Pamela Haylock, PhD, RN, FAAN, past president, Oncology Nursing Society, discusses the role of closed-system drug-transfer devices (CSTDs).


Dawn L. Hershman, MD, MS

Latest:

Ovarian Suppression Plus AI Treatment Can Have Major Adverse Events

Combining ovarian suppression and an aromatase inhibitor is an efficacious treatment method for premenopausal women with breast cancer. However, the regimen (which is given long-term) can cause some major adverse events, explained Dawn L. Hershman, MD, MS, professor of medicine and epidemiology at the Columbia University Irving Medical Center.


Angela Moore, BS

Latest:

Answering Those "Million Dollar" Questions

Two nurse navigators report on the importance of equitable access to care, regardless of a patient's social connections, socioeconomic status, of philanthropy history.


Sunil Verma, MD, MSEd, FRCPC

Latest:

Dr. Verma on Palbociclib Plus Fulvestrant for HR+/HER2- Breast Cancer

Sunil Verma, MD, MSEd, FRCPC, discusses the PALOMA-3 trial, which examined palbociclib with or without fulvestrant for the treatment of patients with HR-positive, HER2-negative breast cancer.


Jill Williams, RN, BSN, NP

Latest:

Reducing Central Line-Associated Bloodstream Infections

Decreasing hospital associated infection rates including Central Line–Associated Bloodstream Infections is an issue of ongoing focus nationwide.


Frahad Ravandi-Kashani, MD

Latest:

Measurable Residual Disease's Role in the Relapse Setting

MRD can prove useful in the treatment of patients with hairy cell leukemia who relapsed.


Charlotte Evans

Latest:

Helping Patients Tell Their Stories

"What's your opinion about using hair color?" I asked my doctor shortly before beginning chemotherapy. "I don't have an opinion," he said. "Talk to one of the nurses."


Tiki Barber

Latest:

Tiki Barber: Oncology Nurses Are "The Rock Patients Lean On"

Tiki Barber, former NFL running back and radio host, explains how he feels about oncology nurses, who helped his mother through her breast cancer experience.


Michael Soulen, MD

Latest:

Michael Soulen on Radioembolization of Neuroendocrine Tumor Liver Metastases

Michael Soulen, MD, a professor of radiology and surgery at the Abramson Cancer Center, University of Pennsylvania, discusses radioembolization to treat liver metastases in patients with neuroendocrine tumors (NETs) as well as the efficacy of embolization in treating NETs.


Ellyn Matthews, PhD

Latest:

Ellyn Matthews on Addressing Sleep Disturbances

Ellyn Matthews, PhD, RN, AOCNS, CBSM, who holds the Elizabeth Stanley Cooper Endowed Chair in Oncology Nursing at the University of Arkansas for Medical Sciences, discusses the role of oncology nurses in handling sleep disturbances.


Courtney Marabella

Latest:

Patients With HER2+ Breast Cancer and Brain Metastases Achieve Better OS With Tucatinib Triplet Regimen

A triplet regimen of tucatinib, trastuzumab, and capecitabine helped patients with HER2-positive metastatic breast cancer and brain metastases live longer with reduced disease progression compared with trastuzumab and capecitabine alone.


Brielle Urciuoli

Latest:

Ketamine May Benefit Those With Difficult Pain From Ovarian Cancer

Ketamine, typically used to kickstart and maintain anesthesia use, could be an option for treating patients with ovarian cancer whose pain is difficult to treat.


Laura Rutledge, MA, RDN, CSO

Latest:

Grilling and Cancer: Turn Down the Summer Heat

What you grill—and how you grill—can potentially produce cancer-causing substances. Here are 3 tips nurses can share with others to reduce the risk of carcinogen formation and still enjoy grilled food.


Sagar Lonial, MD

Latest:

Sagar Lonial Discusses Treating Patients With Myeloma

Sagar Lonial, MD, chief medical officer, Winship Cancer Institute of Emory University and Professor and Executive Vice Chair, Department of Hematology and Medical Oncology, Emory University School of Medicine, discusses treating patients with myeloma.


Kathy Oubre, MS, Chief Operating Officer, Pontchartrain Cancer Center

Latest:

Assessing Barriers to Oral Oncolytic Adherence

Kathy Oubre, MS, Chief Operating Officer, Pontchartrain Cancer Center in Covington, Louisiana, shares some barriers to adherence to oral oncolytics that patients may face.


OLIVER DORIGO, M.D., PH.D.

Latest:

Future Focus: Ovarian Cancer in 2018 and Beyond

Oliver Dorigo, M.D., Ph.D., Associate Professor of Obstetrics and Gynecology (Oncology), Stanford University Medical Center, discusses the work ahead in the ovarian cancer field.


Omid Hamid, MD

Latest:

Omid Hamid on Responses to Single Agent Immunotherapies Compared to Combination

Omid Hamid, MD, compares the responses of patients with melanoma on single-agent immunotherapy treatment to those on combination therapy treatments.


Smita Bhatia

Latest:

Smita Bhatia on Treatment and Risk of Developing Other Cancers

Smita Bhatia, MD, MPH, discusses the relationship between treatment for cancer and the development of other cancers.


Christina Mattina

Latest:

Palliative Care: When Patients Understand It, They Are More Likely to Use It

A recent study determined that an education initiative could help to ease worries patients with cancer may have about palliative care, thus improving quality of life.


IBM Watson Health

Latest:

Hackensack Meridian Health to Pilot Combined Watson for Oncology and Cota Technology to Power Value-Based Clinical Decision Support in Cancer Care

IBM Watson Health, Cota and Hackensack Meridian Health have joined together to help oncologists make evidence- and outcomes-based clinical decisions for their cancer patients, which could reduce total cost of care.


Sharyn Worrall, FightCRC

Latest:

Screening Saves: Know Your Options And Talk to Your Doctor

On March 21, at 9 PM EST, the #CureConnect tweetchat will be focusing on screening and prevention. Sharyn Worrall, Patient Education Manager for FightCRC will be comoderating on this topic, which is especially important for colorectal cancer.


Amelie Harle, MD, PhD

Latest:

Amelie Harle on Aprepitant's Effectiveness in Treating Cough in Lung Cancer

Amelie Harle, an oncologist at Christie Hospital in Manchester, United Kingdom, discusses the possibility of using aprepitant (Emend) to treat cough in patients with lung cancer.


Kathleen Keenan, NP

Latest:

Transitioning Breast Cancer Survivors Back to Primary Care

After being treated for breast cancer, nurse practitioners at MSK help survivors transition back to their primary care physicians.


Marcia Brose, MD, PhD

Latest:

Expert Discusses Updates in Thyroid Cancer

The past 10 years have shown significant updates for treatment of patients with thyroid cancer, beyond just targeted therapies.


Pam McMillan, RN, OCN

Latest:

How Can We Help Patients Who Suffer from CIPN?

Understanding the effects of chemotherapy-induced peripheral neuropathy (CIPN) is imperative to be able to care for our patients better.


Sandra Kelly, RN, MS, NP, Nurse Practitioner, Brigham & Women’s HospitalAllison Tyler, RN, BSN, OCN®, CCRP, Staff Nurse, Cleveland Clinic

Latest:

Immunotherapy: Personalized Treatment for Advanced Prostate Cancer

In April 2010, the FDA approved sipuleucel-T for patients with castration-resistant and metastatic prostate cancer, providing a new treatment that would help the body fight its own cancer.


Richard Dickens, MS, LCSW, Director of Client Advocacy, CancerCare

Latest:

Wounded Healers in Oncology Nursing

By being aware of one’s own woundedness (including the wound of our mortality) we can be more effective healers in our work as healthcare professionals.


Linda G. Hughes, MA

Latest:

Reach Out and Communicate with Your Psycho-Oncology Interdisciplinary Team

Elizabeth Archer-Nanda, DNP, APRN, PMHCNS-BC, psychiatric nurse specialist at the Norton Cancer Institute, would like you to pick up the phone and call your cancer patient's oncologist to set aside just one hour to round with him or her and brainstorm how to help your patient have the best possible quality of life.

© 2024 MJH Life Sciences

All rights reserved.